KRTX's logo.
Ticker Symbol: KRTX

Karuna Therapeutics Inc

$135.12 - 20-11-2024 4 p.m. ET

Exchange: NASDAQ Currency: USD Asset Type: Common Stock CIK:0001771917

Company Profile

Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions.Karuna understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing itsextensive knowledge of neuroscience, the Company is harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples' lives.

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: karunatx.com
CEO: N/A
Tags:
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing

Pricing

Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $171.01
Change: -$5.13 ( -2.91%)
Days Range: $168.24 - $176.35
Beta: 0.95
52wk. High: $245.00
52wk. Low: $158.38
Ytd. Change -15.88%
50 Day Moving Average: $174.49
200 Day Moving Average: $198.12
Shares Outstanding: 37667845

Valuation

Market Cap: 644.2B
PE Ratio: -16.82
EPS (TTM): -10.17

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A